tiprankstipranks
Advertisement
Advertisement

IOVA Stock Latest News

Iovance Biotherapeutics price target raised to $10 from $7 at TD Cowen
The FlyIovance Biotherapeutics price target raised to $10 from $7 at TD Cowen
1d ago
IOVA
Lorusso Boosts Iovance Biotherapeutics Price Target to $10 on Strong Amtagvi Momentum and Operational Upside, Reaffirms Buy Rating
PremiumRatings
Lorusso Boosts Iovance Biotherapeutics Price Target to $10 on Strong Amtagvi Momentum and Operational Upside, Reaffirms Buy Rating
1d ago
IOVA
Iovance Biotherapeutics price target raised to $7 from $4 at UBS
PremiumThe Fly
Iovance Biotherapeutics price target raised to $7 from $4 at UBS
6d ago
IOVA
Iovance Biotherapeutics price target raised to $11 from $10 at Mizuho
PremiumThe Fly
Iovance Biotherapeutics price target raised to $11 from $10 at Mizuho
8d ago
IOVA
Iovance Biotherapeutics put volume heavy and directionally bearish
PremiumThe Fly
Iovance Biotherapeutics put volume heavy and directionally bearish
9d ago
IOVA
Iovance Biotherapeutics price target raised to $6 from $4 at Baird
PremiumThe FlyIovance Biotherapeutics price target raised to $6 from $4 at Baird
19d ago
IOVA
Iovance Biotherapeutics price target raised to $8 from $5 at Citizens
Premium
The Fly
Iovance Biotherapeutics price target raised to $8 from $5 at Citizens
19d ago
IOVA
Iovance Biotherapeutics price target raised to $13 from $11 at Barclays
Premium
The Fly
Iovance Biotherapeutics price target raised to $13 from $11 at Barclays
19d ago
IOVA
Iovance Biotherapeutics Earnings Call Signals Scaled Momentum
PremiumCompany Announcements
Iovance Biotherapeutics Earnings Call Signals Scaled Momentum
20d ago
IOVA
Iovance Biotherapeutics Highlights Strong Q2 Growth and Outlook
PremiumCompany Announcements
Iovance Biotherapeutics Highlights Strong Q2 Growth and Outlook
20d ago
8K
IOVA
Iovance: Strong AMTAGVI Execution and Global Expansion Support Buy Rating with Unchanged $9 Price Target
PremiumRatings
Iovance: Strong AMTAGVI Execution and Global Expansion Support Buy Rating with Unchanged $9 Price Target
20d ago
IOVA
Iovance Expands Solid Tumor Pipeline With New IOV-5001 TIL Trial
PremiumCompany Announcements
Iovance Expands Solid Tumor Pipeline With New IOV-5001 TIL Trial
20d ago
IOVA
Midday Fly By: SanDisk, Western Digital slide despite Q4 beats
PremiumThe FlyMidday Fly By: SanDisk, Western Digital slide despite Q4 beats
20d ago
Z
RL
Iovance Biotherapeutics backs FY26 revenue view $350M-370M, consensus $352M
Premium
The Fly
Iovance Biotherapeutics backs FY26 revenue view $350M-370M, consensus $352M
20d ago
IOVA
Iovance Biotherapeutics reports Q2 EPS (11c), consensus (13c)
Premium
The Fly
Iovance Biotherapeutics reports Q2 EPS (11c), consensus (13c)
20d ago
IOVA
Is IOVA a Buy, Before Earnings?
PremiumPre-Earnings
Is IOVA a Buy, Before Earnings?
22d ago
IOVA
Iovance updates outlook, highlighting Amtagvi growth and pipeline
PremiumCompany Announcements
Iovance updates outlook, highlighting Amtagvi growth and pipeline
2M ago
8K
IOVA
Iovance Biotherapeutics files automatic mixed securities shelf
PremiumThe Fly
Iovance Biotherapeutics files automatic mixed securities shelf
2M ago
IOVA
Iovance Shareholders Approve Expanded Capital Flexibility and Governance
PremiumCompany Announcements
Iovance Shareholders Approve Expanded Capital Flexibility and Governance
3M ago
8K
IOVA
Joseph Pantginis Maintains Buy Rating on Iovance as AMTAGVI’s Global Expansion and Survival Data Support Unchanged $9 Price Target
PremiumRatingsJoseph Pantginis Maintains Buy Rating on Iovance as AMTAGVI’s Global Expansion and Survival Data Support Unchanged $9 Price Target
3M ago
IOVA
Iovance receives Australian approval of Amtagvi for advanced melanoma
Premium
The Fly
Iovance receives Australian approval of Amtagvi for advanced melanoma
3M ago
IOVA
Iovance gets allowance to proceed from FDA for IOV-5001 IND application
Premium
The Fly
Iovance gets allowance to proceed from FDA for IOV-5001 IND application
3M ago
IOVA

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >